Versarien plc (AIM:VRS)
0.0100
+0.0035 (53.85%)
Nov 28, 2025, 5:55 PM GMT
Versarien Revenue
Versarien had revenue of 1.47M GBP in the half year ending March 31, 2025, a decrease of -44.07%. This brings the company's revenue in the last twelve months to 1.39M, down -52.31% year-over-year. In the fiscal year ending September 30, 2024, Versarien had annual revenue of 2.42M, down -18.74%.
Revenue (ttm)
1.39M
Revenue Growth
-52.31%
P/S Ratio
0.43
Revenue / Employee
21.77K
Employees
64
Market Cap
601.00K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 2.42M | -559.00K | -18.74% |
| Sep 30, 2023 | 2.98M | -4.42M | -59.71% |
| Sep 30, 2022 | 7.40M | -229.00K | -3.00% |
| Mar 31, 2022 | 7.63M | 1.95M | 34.27% |
| Mar 31, 2021 | 5.69M | -2.60M | -31.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synthomer | 1.89B |
| Essentra | 295.10M |
| Victrex | 292.70M |
| Zotefoams | 154.16M |
| Treatt | 132.47M |
| Iofina | 42.08M |
| Itaconix | 6.24M |
| Directa Plus | 6.15M |
Versarien News
- 7 weeks ago - UK Stock Market News: Wynnstay, easyJet, Versarien - The Armchair Trader
- 2 months ago - AIM Market Roundup: Caledonian Holdings, Kropz, Ascent - The Armchair Trader
- 2 months ago - AIM Market Roundup: Tomco Energy, Versarien, Mindflair - The Armchair Trader
- 4 months ago - AIM Market Roundup: Oracle Power, Versarien, EnergyPathways - The Armchair Trader
- 5 months ago - AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien - The Armchair Trader
- 5 months ago - Chinese investor pulls out of Versarien deal citing national security review - The Armchair Trader
- 5 months ago - AIM Market Roundup: Cambridge Cognition, Karelian Diamonds, Conroy Gold - The Armchair Trader
- 5 months ago - AIM Market Roundup: Sorted, Versarien, Savannah Resources - The Armchair Trader